| Literature DB >> 25036778 |
Anna-Lena Schmitz1, Ramona Schrage2, Evelyn Gaffal3, Thomas H Charpentier4, Johannes Wiest5, Georg Hiltensperger5, Julia Morschel1, Stephanie Hennen1, Daniela Häußler6, Velten Horn7, Daniela Wenzel8, Manuel Grundmann1, Katrin M Büllesbach1, Ralf Schröder1, H Henning Brewitz9, Johannes Schmidt1, Jesús Gomeza1, Céline Galés10, Bernd K Fleischmann8, Thomas Tüting3, Diana Imhof9, Daniel Tietze7, Michael Gütschow6, Ulrike Holzgrabe5, John Sondek11, T Kendall Harden4, Klaus Mohr2, Evi Kostenis12.
Abstract
In spite of the crucial role of heterotrimeric G proteins as molecular switches transmitting signals from G protein-coupled receptors, their selective manipulation with small molecule, cell-permeable inhibitors still remains an unmet challenge. Here, we report that the small molecule BIM-46187, previously classified as pan-G protein inhibitor, preferentially silences Gαq signaling in a cellular context-dependent manner. Investigations into its mode of action reveal that BIM traps Gαq in the empty pocket conformation by permitting GDP exit but interdicting GTP entry, a molecular mechanism not yet assigned to any other small molecule Gα inhibitor to date. Our data show that Gα proteins may be "frozen" pharmacologically in an intermediate conformation along their activation pathway and propose a pharmacological strategy to specifically silence Gα subclasses with cell-permeable inhibitors.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25036778 PMCID: PMC4337399 DOI: 10.1016/j.chembiol.2014.06.003
Source DB: PubMed Journal: Chem Biol ISSN: 1074-5521